Ligandal

company

About

Ligandal is creating delivery systems and AI-driven targeting approaches for cell-specific and precision genetic medicine.

  • Brooklyn,New York,United States
  • 1 - 10

Details

Last Funding Type
Seed
Industries
Biotechnology,Genetics,Nanotechnology
Founded date
Jan 1, 2014
Number Of Employee
1 - 10
Operating Status
Active
Legal Name
Ligandal Inc.

Ligandal's mission is to create precision delivery platform to cure and treat disease. We are driving the discovery and delivery of a broad array of gene therapies, genetic materials, and gene-specific payloads with unprecedented precision at the cellular and sub-cellular level. Our ligand discovery engine allows for rapid design of diagnostically-responsive materials, capable of shuttling a variety of nucleic acid and protein payloads (including CRISPR and mRNA) to specific cell types. We are initially applying this technology to indications in hematology, immuno-oncology, and infectious disease.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
7
$4.64M
Ligandal has raised a total of $4.64M in funding over 2 rounds. Their latest funding was raised on Feb 1, 2019 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 1, 2019 Seed $1.80M Detail
Oct 24, 2017 Seed 1 Detail
Oct 1, 2017 Seed $2M 2 Detail
Aug 9, 2016 Angel $330K 10 Detail
Aug 6, 2015 Angel $200K 1 Detail

Investors

Number of Lead Investors
Number of Investors
20
Ligandal is funded by 20 investors. Bioverge and Social Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Bioverge Seed
Social Capital Seed
Social Impact Capital Seed
D.A. Wallach Angel
Eric Anschutz Angel
Esther Dyson Angel
Jeff Hammerbacher Angel
Jeremy Yap Angel
Justin Rosenstein Angel
Kauffman Fellows Angel

Employee Profiles

Number of Employee Profiles
3
Ligandal has 3 current employee profiles, including Executive Andre Watson
Executive
Executive
Executive